Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct;39(5):e22144.
doi: 10.1002/jca.22144.

Mitigating the Prozone-Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody-Mediated Rejection Post-Heart Transplantation

Affiliations
Case Reports

Mitigating the Prozone-Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody-Mediated Rejection Post-Heart Transplantation

Sarah K Grewal et al. J Clin Apher. 2024 Oct.

Abstract

Therapeutic plasma exchange (TPE) is a cornerstone treatment for antibody-mediated rejection (AMR) post-organ transplantation, aiming to eliminate pathogenic donor-specific HLA antibodies (DSA). However, limitations in HLA antibody interpretation due to the prozone-like effect (PLE) can lead to inaccurate assessment of treatment efficacy. We present a case of a heart transplant recipient with suspected AMR, where an unexpected increase in DSA levels post-TPE prompted investigation into PLE. Solid-phase Luminex assays were employed to detect HLA antibodies. Serum was run neat as well as after treatment with ethylenediaminetetraacetic acid (EDTA). Nephelometry was used to detect complement levels. Laboratory analysis of pre-TPE serum revealed higher DSA levels with EDTA treatment, characteristic of PLE. Complement measurements supported complement-mediated interference in the pre-TPE sample. This case underscores the importance of being aware that PLE can occur in HLA testing and can impact the interpretation of TPE efficacy for AMR.

Keywords: HLA; MFI; antibody mediated rejection; plasma exchange; prozone‐like effect.

PubMed Disclaimer

References

    1. R. Pei, J. H. Lee, N. J. Shih, M. Chen, and P. I. Terasaki, “Single Human Leukocyte Antigen Flow Cytometry Beads for Accurate Identification of Human Leukocyte Antigen Antibody Specificities,” Transplantation 75 (2003): 43–49.
    1. V. Kosmoliaptsis, J. A. Bradley, S. Peacock, A. N. Chaudhry, and C. J. Taylor, “Detection of Immunoglobulin G Human Leukocyte Antigen‐Specific Alloantibodies in Renal Transplant Patients Using Single‐Antigen‐Beads Is Compromised by the Presence of Immunoglobulin M Human Leukocyte Antigen‐Specific Alloantibodies,” Transplantation 87 (2009): 813–820.
    1. M. Schnaidt, C. Weinstock, M. Jurisic, B. Schmid‐Horch, A. Ender, and D. Wernet, “HLA Antibody Specification Using Single‐Antigen Beads—A Technical Solution for the Prozone Effect,” Transplantation 92 (2011): 510–515.
    1. A. L. Greenshields and R. S. Liwski, “The ABCs (DRDQDPs) of the Prozone Effect in Single Antigen Bead HLA Antibody Testing: Lessons From our Highly Sensitized Patients,” Human Immunology 80 (2019): 478–486.
    1. L. Connelly‐Smith, C. R. Alquist, N. A. Aqui, et al., “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis: The Ninth Special Issue,” Journal of Clinical Apheresis 38 (2023): 77–278.

Publication types